The Evolution of Policy Issues in Stem Cell Research: An International Survey

Stem Cell Reviews and Reports

Volumn 8, Issue 4, 2012, Pages 1037-1042

  Caulfield, Timothy ^a   Rachul, Christen ^a   Zarzeczny, Amy ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF REGINA   (Canada)

Author keywords

Clinical translation; Commercialization; Debate; Ethics; Moral status of the embryo; Policy; Stem cell research

Indexed keywords

ANIMAL; ARTICLE; BIOETHICS; ECONOMICS; HUMAN; INFORMATION PROCESSING; LEGAL ASPECT; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; STANDARD; STEM CELL;

ANIMALS; BIOETHICAL ISSUES; BIOETHICS; BIOMEDICAL RESEARCH; DATA COLLECTION; HUMANS; STEM CELLS;

EID: 84870357334     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9404-5     Document Type: Article

References (22)

1. Neate, R. (2 Oct 2011). Stem cell centre gets green light from UK government. The Guardian. http://www. guardian. co. uk/business/2011/oct/02/stem-cell-centre-government-investment. Accessed 15 June 2012.
2. Caulfield, T. (2010). Stem cell research and economic promises. The Journal of Law, Medicine & Ethics, 38, 303-313.
3. Hyun, I. (2010). The bioethics of stem cell research and therapy. The Journal of Clinical Investigation, 120(1), 71-75.
4. Blendon, R., Kim, M. K., & Benson, J. (2011). The public, political parties, and stem-cell research. The New England Journal of Medicine, 365(20), 1853-1856.
5. Tumulty, K. (29 Jan 2012). Gingrich vows to ban embryonic stem-cell research, questions in vitro practices. The Washington Post. http://www. washingtonpost. com/politics/gingrich-vows-to-ban-embryonic-stem-cell-research-questions-in-vitro-practices/2012/01/29/gIQAIO9saQ_story. html. Accessed 3 May 2012.
6. Young, S. (2012). Candidates play to the right on science; rivals for the Republican nomination laud research but take a hard line on embryonic stem cells and climate. Nature, 481, 421-423.
7. Caulfield, T., & Bubela, T. (2007). Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate. The American Journal of Bioethics, 7(2), 1-11.
8. Zarzeczny, A., Scott, C., Hyun, I., Bennett, J., Chandler, J., Chargé, S., et al. (2009). iPS cells: mapping the policy issues. Cell, 139(6), 1032-1037.
9. California Institute of Regenerative Medicine. About CIRM. http://www. cirm. ca. gov/about-cirm. Accessed 3 May 2012.
10. Zarzeczny, A., & Caulfield, T. (2009). Emerging ethical, legal and social issues associated with stem cell research and the current role of the moral status of the embryo. Stem Cell Reviews and Reports, 5(2), 96-101.
11. Lovell-badge, R. (2011). Stem cell scientists will simply switch to U. S. if investment cannot be protected. The Daily Mail (United Kingdom). http://www. dailymail. co. uk/news/article-2050737/Stem-cell-scientists-switch-US-investment-protected. html. Accessed 25 July 2012.
12. Vrtovec, K. T., & Scott, C. T. (2011). The European Court of Justice ruling in Brüstle v. Greenpeace: the impacts on patenting of human induced pluripotent stem cells in Europe. Cell Stem Cell, 9, 502-503.
13. Little, M., Hall, W., & Orlandi, A. (2006). Delivering on the promise of human stem-cell research: what are the real barriers? EMBO Reports, 7(12), 1188-1192.
14. Bubela, T., & Caulfield, T. (2010). Role and reality: technology transfer at Canadian universities. Trends in Biotechnology, 28, 447-451.
15. Lau, D., Ogbogu, U., Taylor, B., Stafinski, T., Menon, D., & Caulfield, T. (2008). Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell, 3, 591-594.
16. Levine, A. (2010). Stem cell tourism: assessing the state of knowledge. ScriptED, 7(2), 274-282.
17. Regenberg, A., Hutchinson, L., Schanker, B., & Matthews, D. (2009). Medicine on the fringe: stem cell-based interventions in advance of evidence. Stem Cells, 27, 2312-2319.
18. Cyranoski, D. (2012). Stem-cell therapy takes off in Texas: a boom in unproven procedures is worrying scientists. Nature, 483, 13-14.
19. Zarzeczny, A., Rachul, C., Caulfield, T. (2012). The phenomenon of stem cell tourism. In A. Atala (Ed.), Progenitor and stem cell technologies and therapies: Principles and Issues, Vol 1. Philadelphia: Woodhead Publishing.
20. Cyranoski, D. (2011). Texas prepares to fight for stem cells. Nature, 477, 377-378.
21. Bubela, T., & Caulfield, T. (2010). Role and reality: technology transfer at Canadian universities. Trends in Biotechnology, 28(9), 447-451.
22. Caulfield, T., Harmon, S., & Joly, Y. (2012). Open science versus commercialization: a modern research conflict? Genome Medicine, 4, 17.